HETEROCYCLES
An International Journal for Reviews and Communications in Heterocyclic ChemistryWeb Edition ISSN: 1881-0942
Published online by The Japan Institute of Heterocyclic Chemistry
e-Journal
Full Text HTML
Received, 28th August, 2012, Accepted, 1st October, 2012, Published online, 16th October, 2012.
DOI: 10.3987/COM-12-S(N)112
■ NEW INDOLE ALKALOIDS FROM ALSTONIA MACROPHYLLA
Jun Deguchi, Tomokazu Shoji, Yusuke Hirasawa, Abdul Rahman, Osamu Shirota, and Hiroshi Morita*
Faculty of Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
Abstract
Alkaloidal investigations of Alstonia macrophylla led to the isolation of a new 3-alkylpyridinium-indole-2-carboxylate scaffold alkaloid, N(1)-demethyl-7-methoxyikirydinium A (1) and a yohimbane-type alkaloid, 10-methoxydihydrosempervirine (2), and two strychane-type alkaloids, 17-carboxylcompactivervine N-oxide (3) and 17-carboxylalstovine N-oxide (4). Their structures were elucidated by NMR spectral analysis using 2D techniques and CD spectra.Plants of the genus Alstonia (Apocynaceae) are widely distributed in tropical regions of Africa and Asia. Several species of Alstonia used in traditional medicine throughout Southeast Asia for the treatment of malaria and other ailments including tumours.1 In the course of our investigation of bioactive indole alkaloids from tropical plants belonging to Apocynaceae, we have reported four new picraline and ajmaline-type indole alkaloids, alstiphyllanines A-D, which showed antiplasmodial activity against Plasmodium falciparum and vasorelaxant activity,2 and alstiphyllanines E-H, which have biological activities such as vasorelaxant activity and inhibiting sodium glucose cotransporter,3 from A. macrophylla collected in Indonesia. In this paper we would like to report the isolation and structure elucidation of new alkaloids 1-4 from A. macrophylla collected in Indonesia.
RESULTS AND DISCUSSION
N(1)-Demethyl-7-methoxyikirydinium A (1) showed the pseudomolecular ion peak at m/z 325 (M+H)+ in ESIMS, and the molecular formula, C19H20N2O3, was established by HRESIMS [m/z 325.15862, (M+H)+ Δ +3.40 mDa]. IR spectrum showed absorption bands (3435 and 1675 cm-1) characteristic of carboxylic acid. The 1H NMR data (Table 1) showed the presence of a 3-ethylpyridinium, a 1,2,4-trisubstituted benzene, and a 1,2-disubstitued ethane. Diagnostic 2D NMR correlations (Figure 1) indicated an assembly of these structure fragments. The position of a methoxy group was confirmed by an HMBC correlation of O-Me to C-7 (δC 160.2). The molecular formula of 1 was larger than that of ikirydinium A isolated from Hunteria umbellata4 by an oxygen atom. Compared with 1H NMR data of ikirydinium A, the presence of a 3-alkylpyridinium-indole-2-carboxylate backbone without an N-methyl group was suggested for 1.
10-Methoxydihydrosempervirine (2) showed the pseudomolecular ion peak at m/z 305 (M+H)+ in ESIMS, and the molecular formula, C20H20N2O, was established by HRESIMS [m/z 305.16528, (M+H)+ Δ +0.44 mDa]. The UV spectrum of 2 was similar to that of sempervirine.5 The 1H NMR spectrum that showed signals corresponding to five aromatic and twelve aliphatic protons were very similar to those of sempervirine that possessed two singlet aromatic protons except for a methoxy group. HMBC cross peaks indicated the presence of a methoxy group attached to C-10 (δC 156.5). The 1H-1H COSY correlations between H2-5 (δH 4.79) to H2-6 (δH 3.37) and H2-16 (δH 3.06) to H2-19 (δH 2.91) indicated the presence of the two sp3 methylene sequences and HMBC correlations between H2-5 to C-3 (δC 141.7) and C-21 (δC 145.1), and H2-6 to C-2 (δC 126.3) and C-8 (δC 126.7) suggested 2 was a dihydrosempervirine derivative as shown in Figure 2.
ESIMS spectra of 17-carboxylcompactivervine N-oxide (3) and 17-carboxylalstovine N-oxide (4) showed the pseudomolecular ion peak at m/z 359 (M+H)+ and 389 (M+H)+, respectively, and the molecular formulae were established to be C19H22N2O5 and C20H24N2O6 by HRESIMS [3: m/z 359.16299, (M+H)+ Δ +2.29 mDa; 4: m/z 389.17386, (M+H)+ Δ +2.60 mDa], respectively. IR spectra of 3 and 4 showed a typical absorption bands (3: 3329 and 1614 cm-1; 4: 3514 and 1612 cm-1) for carboxylic acid. Based on the 1H and 13C NMR spectra (Tables 1 and 2), signal patterns of 3 and 4 were very similar to those of compactinervine (5)6 and alstovine (6)7 except for methyl ester group, respectively, which indicated that 3 and 4 contained a strychane skeleton. The structures of 3 and 4 were finally established by 2D NMR correlations and, 3 and 4 were indicated the calboxylic acid derivatives of the known alkaloids, 5 and 6. Low field chemical shifts at C-3, C-5, and C-21 around N-4 atom [C-3 (δC 62.7 → δC 75.8), C-5 (δC 53.5 → δC 68.3), and C-21 (δC 53.1 → δC 65.4)] on comparison with those in 5 and [C-3 (δC 60.5 → δC 76.1), C-5 (δC 51.5 → δC 68.8), and C-21 (δC 53.8 → δC 65.4)] on comparison with those in 6, suggested that 3 and 4 were N-oxide form at N-4.
The relative stereochemistry of 3 and 4 were elucidated by NOESY correlations as shown in computer-generated 3D drawing (Figure 4). The relative configurations of C-19 and C-20 were also deduced by comparison of 13C NMR spectra of 5 and 6, and of 3 and 4, which were in excellent agreement with Verpoorte’s data8 on 5 and Men-Olivier’s data9 on 6. The structures of 3 and 4 were confirmed by chemical conversion from compactivervine (5) and alstovine (6). Oxidation of 5 with mCPBA in CHCl3 gave compactivervine N(4)-oxide, which, upon LiOH hydrolysis in aqueous MeOH gave 3. The similar patterns of Cotton effects in the CD spectra of 3 and 4 [3: λmax 203 (Δε +44.6), 239 (Δε +20.8) and 316 (Δε -40.8) nm, 4: λmax 212 (Δε +32.1), 228 (Δε +27.3) and 310 (Δε -33.5) nm] indicated that the chiral centers have the same absolute configurations as that of 17-carboxyl-N(4)-methylechitamidine chloride [λmax 206 (Δε +35.7), 239 (Δε +16.6) and 312 (Δε -34.9) nm].10 Thus, 17-carboxylcompactivervine N-oxide and 17-carboxylalstovine N-oxide were assigned to be 3 and 4, respectively.
EXPERIMENTAL
General Experimental Procedures. Optical rotations were measured on a JASCO DIP-1000 automatic digital polarimeter. UV spectra were obtained on an Ultrospec 2100 pro spectrophotometer, CD spectra were measured on a JASCO J-820 spectropolarimeter, and IR spectra were recorded on a JASCO FT/IR-4100 spectrophotometer. Positive-mode ESI mass spectra were obtained on a WatersQ-Tof premier spectrometer. High-resolution ESIMS were obtained on a LTQ Orbitrap XL (Thermo Scientific). HPLC was carried out using a JASCO PU-2089 Plus pump equipped with a UV-2075 Plus detector (λ 254 nm) and CAPCELL PAK C-18 MG-II columns (for analytical HPLC, 250 × 4.6 mm i.d., 5 μm particle size, and for preparative HPLC, 250 × 10 mm i.d., 5 μm particle size, Shiseido, Tokyo, Japan). 1H and 13C NMR spectra were obtained on a Varian INOVA 600 spectrometer using TMS as an internal standard. HSQC experiments were optimized for 1JCH = 140 Hz and HMBC experiments for nJCH = 8 Hz.
Plant Material. The stems of Alstonia macrophylla were collected in Java, Indonesia, in 2007. The botanical identification was made by Ms. Sri Wuryanti, Purwodadi Botanical Garden, Indonesia. A voucher specimen (no. AP070902) has been deposited at Purwodadi Botanical Garden, Pasuruan, Indonesia.
Extraction and Isolation. The stems of A. macrophylla (4.7 kg) were crushed and extracted with MeOH. The MeOH extract (20 g) was treated with 3% tartaric acid (pH 2) and then partitioned with EtOAc. The aqueous layer was treated with saturated Na2CO3 aqueous solution to pH 9 and extracted with CHCl3 and n-BuOH, successively. The CHCl3-soluble fraction was purified by a SiO2 column (NH3 sat. CHCl3/MeOH/H2O, 1:0:0→5:5:1). The fractions eluted with CHCl3/MeOH (7:3) was purified with ODS HPLC (MeOH/H2O/TFA, 50:50:0.1) to afford 10-methoxydihydrosempervirine (2, 1.0 mg, 0.005%) together with two known alkaloids, compactinervine (5) and alstovine (6). The n-BuOH -soluble fraction was purified by a HP-20 column (H2O/MeOH 1:0 → 0:1). The fractions eluted with H2O/MeOH (60:40) and H2O/MeOH (50:50) were purified with an ODS column (H2O/MeOH 1:0 → 0:1), followed by an ODS HPLC (MeOH/H2O/HCOOH, 30:70:1) to afford N(1)-demethyl-7-methoxyikirydinium A (1, 0.7 mg, 0.004%), 17-carboxylcompactivervine N-oxide (3, 1.1 mg, 0.006%), and 17-carboxylalstovine N-oxide (4, 1.5 mg, 0.008%).
N(1)-Demethyl-7-methoxyikirydinium A (1): brown amorphous solid; IR (KBr) νmax 3435 and 1675 cm-1; UV (MeOH) λmax 310 (ε 7200), 246sh (ε 8000), 220 (ε 18000), and 201 (ε 19000) nm; 1H and 13C NMR, see Tables 1 and 2; HRESIMS [m/z 325.15862, (M+H)+, calcd for C19H21N2O3, 325.15522].
10-Methoxydihydrosempervirine (2): brown amorphous solid; IR (KBr) νmax 1640 cm-1; UV (MeOH) λmax 395 (ε 3500), 321 (ε 3200), 227 (ε 7400), and 206 (ε 9500) nm; 1H and 13C NMR, see Tables 1 and 2; HRESIMS (m/z 305.16528 [(M+H)+, calcd for C20H21N2O, 305.16484].
17-Carboxylcompactivervine N-oxide (3): brown amorphous solid; [α]D27 -188 (c 0.1, MeOH); IR (KBr) νmax 3329 and 1614 cm-1; UV (MeOH) λmax 323 (ε 1400), 289 (ε 2600), 230sh (ε 4600), and 204 (ε 12000) nm; CD (MeOH) 203 (Δε +44.6), 239 (Δε +20.8) and 316 (Δε -40.8) nm; 1H and 13C NMR, see Tables 1 and 2; HRESIMS (m/z 359.16299 [(M+H)+, calcd for C19H23N2O5, 359.16070].
17-Carboxylalstovine N-oxide (4): brown amorphous solid; [α]D27 -211 (c 0.1, MeOH); IR (KBr) νmax 3514 and 1612 cm-1; UV (MeOH) λmax 293 (ε 3400), 233sh (ε 6700), and 204 (ε 13000) nm; CD (MeOH) 212 (Δε +32.1), 228 (Δε +27.3) and 310 (Δε -33.5) nm; 1H and 13C NMR, see Tables 1 and 2; HRESIMS (m/z 389.17386 [(M+H)+, calcd for C20H25N2O6, 389.17126].
Chemical Transformation of Compactinervine (5) into 17-Carboxylcompactivervine N-oxide (3). m-Chloroperoxybenzoic acid (2 equv.) was added to a stirred solution of compactinervine (5) (1.5 mg) in CHCl3 (0.5 mL) at rt. The mixture was stirred at rt for 3 h. The solution was diluted with CHCl3, washed with 20% Na2CO3 (aq) and then with H2O, and concentrated to give a pale yellow oil (1.1 mg), which was used without purification in the next step. The crude N-oxide alkaloid was treated with LiOH (5 mg) in an aqueous MeOH (1:1), and the reaction mixture was stirred for 8 h at 60 ℃. The resulting mixture was then adjusted to pH = 6 with 2 M HCl (aq) and extracted with n-BuOH. The combined organic extracts were evaporated in vacuo. The crude alkaloid was purified by column chromatography (C18 silica gel eluted with 1% aqueous formic acid/MeOH from 90:10 to 0:100) to give the 17-carboxyl-N-oxide derivative (0.9 mg), whose spectral data were identical with those of 17-carboxylcompactivervine N-oxide (3). In the same way, alstovine (6) (1.5 mg) was transformed into 17-carboxylalstovine N-oxide (4) (0.9 mg).
ACKNOWLEDGMENTS
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a grant from The Open Research Center Project.
References
1. L. M. Petty and J. Metzger, Medicinal Plants of East and Southeast Asia, MIT, Cambridge, Massachusetts., 1980; J. L. Hartwell, Lloydia, 1967, 30, 379; L. Phuphattanaphong, Thai medicinal plants, Part 2, Nwethammada, Bangkok, 1979.
2. Y. Hirasawa, H. Arai, K. Zaima, R. Oktarina, A. Rahman, W. Ekasari, A. Widyawaruyanti, G. Indrayanto, N. C. Zaini, and H. Morita, J. Nat. Prod., 2009, 72, 304. CrossRef
3. H. Arai, Y. Hirasawa, A. Rahman, I. Kusumawati, N. C. Zaini, S. Sato, C, Aoyama, J. Takeo, and H. Morita, Bioorg. Med. Chem., 2010, 18, 2152. CrossRef
4. O. S. Ajala, A. M. Piggott, F. Plisson, Z. Khalil, X. Huang, S. A. Adesegun, H. A. B. Coker, and R. J. Capon, Tetrahedron Lett., 2011, 52, 7125. CrossRef
5. R. B. Woodward and W. M. McLamore, J. Am. Chem. Soc., 1949, 71, 379; CrossRef G. W. Gribble, T. C. Barden, and D. A. Johnson, Tetrahedron, 1988, 44, 3195; CrossRef A. Chatterjee, A. Sahu, M. Saha, and J. Banerji, Monatsh. Chem., 1996, 127, 1259. CrossRef
6. B. Gilbert, A. P. Duarte, Y. Nakagawa, J. AQ. Joule, S. E. Flores, J. Aguayo Brissolese, J. Capello, E. P. Carrazzoni, R. J. Owellen, E. C. Blossey, K. S. Brown, Jr., and C. Djerassi, Tetrahedron, 1965, 21, 1141. CrossRef
7. M. K. Stylianos, S. Thierry, T. Claude, and P. Pierre, Phytochemistry, 1975, 14, 1637. CrossRef
8. R. Verpoorte, E. Kos-Kuyck, A. Tjin A Tsoi, C. L. M. Ruigrok, G. de Jong, and A. Baerheim Svendsen, Planta Med., 1983, 48, 283. CrossRef
9. B. Legseir, A. Cherif, B. Richard, J. Pusset, S. Labarre, G. Massiat, and L. L. Men-Olivier, Phytochemistry, 1986, 25, 1735. CrossRef
10. L. Gan, S. Yang, Y. Wu, J. Ding, and J. Yue, J. Nat. Prod., 2006, 69, 18. CrossRef